Singapore, June 1 -- Cell and gene therapy developers continue to face mounting pressure to improve manufacturing efficiency while maintaining product quality and scalability. Traditional magnetic bead based cell isolation methods, although widely adopted, often introduce additional processing steps, specialised equipment requirements, and operational complexities that can impact yield, cost, and manufacturing consistency. Bracco's BubbleGen platform is seeking to address these challenges through a novel microbubble based approach designed to simplify cell selection and activation workflows. In this Q&A with BioSpectrum Asia, Thierry Bettinger, PhD, Director of Research and Development at Bracco, shares insights into the technology's adva...